Search Results - "Moraes, Priscila M. G."

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the TP53 R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis by Lopes, Carlos D. H., Antonacio, Fernanda F., Moraes, Priscila M. G., Asprino, Paula F., Galante, Pedro A. F., Jardim, Denis L., de Macedo, Mariana P., Sandoval, Renata L., Katz, Artur, de Castro, Gilberto, Achatz, Maria Isabel

“…In southern and southeastern Brazil, the TP53 founder variant c.1010G>A (R337H) has been previously documented with a prevalence of 0.3% within the general…”
Get full text

Real-world Data for High-risk Stage II Colorectal Cancer – The Role of Tumor Side in the Adjuvant Setting by Araujo, Camila S., Venchiarutti Moniz, Camila M., Bonadio, Renata C., Watarai, Gabriel Y., Rojas, Jéssica, Nogueira, Pedro V.S., Martinez, Jéssica K., Moraes, Priscila M.G., Braghiroli, Maria I., Sabbaga, Jorge, Hoff, Paulo M.

“…The impact of sidedness in the high-risk stage II colorectal cancer (CRC) setting is uncertain. Although controversial, available data suggest a possible…”
Get full text

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the ITP53/I R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis by Lopes, Carlos D. H, Antonacio, Fernanda F, Moraes, Priscila M. G, Asprino, Paula F, Galante, Pedro A. F, Jardim, Denis L, de Macedo, Mariana P, Sandoval, Renata L, Katz, Artur, de Castro, Gilberto, Achatz, Maria Isabel

“…In southern and southeastern Brazil, the TP53 founder variant c.1010G>A (R337H) has been previously documented with a prevalence of 0.3% within the general…”
Get full text